Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by fossi_2002on Nov 10, 2022 10:56am
234 Views
Post# 35088431

Future

Future
Q3 results are out and the stock market has reacted. That's it for now.
Now the stock market will look to the future again, and we can be confidently optimistic about this.

Never in Ceapro's past has the future been so broad. All projects have great future opportunities - and all projects are paid for by the core business.

Compare Ceapro with other small companies and you will see how much money they burn quarter after quarter and constantly have to issue new shares to finance their research activities.

The course is not being set now, it is already pointing in the right direction.
By the end of 2023, Ceapro will be a company with a completely different face and with a completely different stock market valuation.

Those on the bullboard who are still whining bought at the wrong time. Now they are whining because they missed the time to get in again. They will probably never make money on the stock market.


<< Previous
Bullboard Posts
Next >>